Methazolamide Is a New Hepatic Insulin Sensitizer That Lowers Blood Glucose In Vivo

We previously used Gene Expression Signature technology to identify methazolamide (MTZ) and related compounds with insulin sensitizing activity in vitro. The effects of these compounds were investigated in diabetic db/db mice, insulin-resistant diet-induced obese (DIO) mice, and rats with streptozotocin (STZ)-induced diabetes. MTZ reduced fasting blood glucose and HbA1c levels in db/db mice, improved glucose tolerance in DIO mice, and enhanced the glucose-lowering effects of exogenous insulin administration in rats with STZ-induced diabetes. Hyperinsulinemic-euglycemic clamps in DIO mice revealed that MTZ increased glucose infusion rate and suppressed endogenous glucose production. Whole-body or cellular oxygen consumption rate was not altered, suggesting MTZ may inhibit glucose production by different mechanism(s) to metformin. In support of this, MTZ enhanced the glucose-lowering effects of metformin in db/db mice. MTZ is known to be a carbonic anhydrase inhibitor (CAI); however, CAIs acetazolamide, ethoxyzolamide, dichlorphenamide, chlorthalidone, and furosemide were not effective in vivo. Our results demonstrate that MTZ acts as an insulin sensitizer that suppresses hepatic glucose production in vivo. The antidiabetic effect of MTZ does not appear to be a function of its known activity as a CAI. The additive glucose-lowering effect of MTZ together with metformin highlights the potential utility for the management of type 2 diabetes.

• Publication year

  2012

• Venue

  Diabetes

• Publication date

  2012-07-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2337/db11-0578PMID 22586591PMCID 3402314
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diabetes

  2013cited by this paper
• A gene expression signature for insulin resistance.

  2011cited by this paper
• Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.

  2010cited by this paper
• An energetic tale of AMPK-independent effects of metformin.

  2010cited by this paper
• Individualizing therapies in type 2 diabetes mellitus based on patient characteristics: what we know and what we need to know.

  2010cited by this paper
• Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes

  2009cited by this paper
• Effects of Insulin on the Metabolic Control of Hepatic Gluconeogenesis In Vivo

  2009cited by this paper
• Berberine and Its More Biologically Available Derivative, Dihydroberberine, Inhibit Mitochondrial Respiratory Complex I

  2008cited by this paper
• Diuretics: from classical carbonic anhydrase inhibitors to novel applications of the sulfonamides.

  2008cited by this paper
• Metformin Inhibits Hepatic Gluconeogenesis Through AMP-Activated Protein Kinase–Dependent Regulation of the Orphan Nuclear Receptor SHP

  2008cited by this paper
• Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and enhanced glycolysis dependency in human tumor cells.

  2007influential reference
• Metabolic Side Effects and Cardiovascular Events of Diuretics: Should a Diuretic Remain the First Choice Therapy in Hypertension Treatment? The Case of Yes

  2007cited by this paper
• Inhibition of hypoxia-induced calcium responses in pulmonary arterial smooth muscle by acetazolamide is independent of carbonic anhydrase inhibition.

  2007cited by this paper
• Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver.

  2007cited by this paper
• Pulmonary vasodilation by acetazolamide during hypoxia is unrelated to carbonic anhydrase inhibition.

  2007cited by this paper
• The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin

  2005cited by this paper
• Molecular physiology and pathophysiology of electroneutral cation-chloride cotransporters.

  2005cited by this paper
• β-Cell Glucose Toxicity, Lipotoxicity, and Chronic Oxidative Stress in Type 2 Diabetes

  2004cited by this paper
• Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes.

  2004cited by this paper
• Metformin prevents the development of acute lipid-induced insulin resistance in the rat through altered hepatic signaling mechanisms.

  2004cited by this paper
• Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions?

  2004cited by this paper
• Gene expression–based high-throughput screening(GE-HTS) and application to leukemia differentiation

  2004cited by this paper
• Long-Term Adaptation of Renal Ion Transporters to Chronic Diuretic Treatment

  2004cited by this paper
• A gene-expression signature as a predictor of survival in breast cancer.

  2002cited by this paper
• Na+:HCO3- cotransporters (NBC): expression and regulation in the kidney.

  2002cited by this paper
• Dimethylbiguanide Inhibits Cell Respiration via an Indirect Effect Targeted on the Respiratory Chain Complex I*

  2000cited by this paper
• Mechanism by which metformin reduces glucose production in type 2 diabetes.

  2000cited by this paper
• Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain.

  2000cited by this paper
• Diuretic complications.

  2000cited by this paper
• Prevention

  1994cited by this paper
• Glycogenesis from glucose and ureagenesis in isolated perfused rat livers. Influence of ammonium ion, norvaline, and ethoxyzolamide.

  1994cited by this paper
• Carbonic anhydrases in cytosol, nucleus, and membranes of rat liver.

  1993cited by this paper
• Expression of hepatic mitochondrial carbonic anhydrase V.

  1990cited by this paper
• Differential regulation of hepatic carbonic anhydrase isozymes in the streptozotocin-diabetic rat.

  1990cited by this paper
• Furosemide causes acute and long-term hyperglycaemia and reduces glucose tolerance in mice.

  1988cited by this paper
• Inhibition of CA V decreases glucose synthesis from pyruvate.

  1986cited by this paper
• Calculation of substrate oxidation rates in vivo from gaseous exchange.

  1983cited by this paper
• Effects of acetazolamide on insulin release, serum glucose and insulin, glucose tolerance, and alloxan sensitivity of mice.

  1980cited by this paper
• Effect of acetazolamide on insulin sensitivity in dogs with alloxan diabetes.

  1978cited by this paper
• Effect of acetazolamide on insulin sensitivity in dogs with alloxan diabetes.

  1978cited by this paper
• Action of acetazolamide on liver pyruvate carboxylase activity, glycogenolysis and gluconeogenesis of mice.

  1978cited by this paper
• The pharmacology of methazolamide in relation to the treatment of glaucoma.

  1977influential reference
• New methods for calculating metabolic rate with special reference to protein metabolism

  1949cited by this paper

• Systemic Carbonic Anhydrase Inhibitors in Common Ophthalmic Diseases: A Scoping Review from A Clinical Standpoint

  2025cites this paper
• A novel discovery platform for targeted drug repurposing: application for psychiatric disorders.

  2025cites this paper
• Ketogenic diet-induced bile acids protect against obesity through reduced calorie absorption

  2024cites this paper
• Use of a gene expression signature to identify trimetazidine for repurposing to treat bipolar depression

  2023cites this paper
• Methazolamide Attenuates the Development of Diabetic Cardiomyopathy by Promoting β-Catenin Degradation in Type 1 Diabetic Mice.

  2022cites this paper
• Imatinib and methazolamide ameliorate COVID-19-induced metabolic complications via elevating ACE2 enzymatic activity and inhibiting viral entry

  2022cites this paper
• Detection, identification, characterization, and HPLC quantification of five impurities from a methazolamide product.

  2022cites this paper
• Modern computational intelligence based drug repurposing for diabetes epidemic.

  2021cites this paper
• Carbonic Anhydrase 1-Mediated Calcification Is Associated With Atherosclerosis, and Methazolamide Alleviates Its Pathogenesis

  2019cites this paper
• Drug-induced diabetes type 2: In silico study involving class B GPCRs

  2019influential citation
• Gene expression signature: a powerful approach for drug discovery in diabetes.

  2017cites this paper
• N-acyl Taurines and Acylcarnitines Cause an Imbalance in Insulin Synthesis and Secretion Provoking β Cell Dysfunction in Type 2 Diabetes.

  2017cites this paper
• Bezafibrate ameliorates diabetes via reduced steatosis and improved hepatic insulin sensitivity in diabetic TallyHo mice

  2017cites this paper
• Carbonic Anhydrase: A New Therapeutic Target for Managing Diabetes

  2016cites this paper
• Repurposing Drugs to Target the Diabetes Epidemic.

  2016cites this paper
• The Metabolism of Methazolamide in Immortalized Human Keratinocytes, HaCaT Cells

  2016cites this paper
• Inhibition of Carbonic Anhydrase Results in Blood Lactate Accumulation(BLA) in STZ Induced Diabetic Rats

  2015cites this paper
• The noncarbonic anhydrase inhibiting acetazolamide analog N-methylacetazolamide reduces the hypercapnic, but not hypoxic, ventilatory response

  2015cites this paper
• Impaired Translocation of GLUT4 Results in Insulin Resistance of Atrophic Soleus Muscle

  2015cites this paper
• Efficacy and Safety of Oral Methazolamide in Patients With Type 2 Diabetes: A 24-Week, Placebo-Controlled, Double-Blind Study

  2014cites this paper
• Characterization of the heterozygous glucokinase knockout mouse as a translational disease model for glucose control in type 2 diabetes

  2014cites this paper
• Metformin Supports the Antidiabetic Effect of a Sodium Glucose Cotransporter 2 Inhibitor by Suppressing Endogenous Glucose Production in Diabetic Mice

  2014cites this paper
• Safety of carbonic anhydrase inhibitors

  2014cites this paper
• The regulation of glucose metabolism: implications and considerations for the assessment of glucose homeostasis in rodents.

  2014cites this paper
• AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism[S]

  2013cites this paper
• A global approach to dissecting lipid-induced impairment of liver gluconeogenesis

  2013influential citation
• Decrease of Hyperglycemia by Syringaldehyde in Diabetic Rats

  2013cites this paper
• Discovery of P1736, a Novel Antidiabetic Compound That Improves Peripheral Insulin Sensitivity in Mice Models

  2013cites this paper